| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |